Research and Markets
The 2009 Comprehensive Study on the Leukemia Drug Pipeline
Published in Blood Weekly, March 19th, 2009
Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today more than 240 therapeutics targeting leukemia in active development, from early preclinical to marketed drugs. In addition, the accumulated number of ceased drugs over the last three years amount to another 63 drugs. Leukemia Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 148 different...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-03-19)
More Articles from Blood Weekly
- Federation of American Societies for Experimental Biology
From stem cells to new organs: Stanford and NYU scientists cross threshold in regenerative medicine - Samuel Lunenfeld Research Institute
Mount Sinai Hospital researcher makes stem cell breakthrough - Acute Myeloid Leukemia
Research in the area of acute myeloid leukemia reported from T.A. Fehniger and colleagues - Acute Pancreatitis
Research on acute pancreatitis detailed by scientists at Shanghai Jiao Tong University - Acute Pancreatitis
Studies in the area of acute pancreatitis reported from M. Wittau and co-researchers - Acute Promyelocytic Leukemia
New acute promyelocytic leukemia study results from University of Texas described - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
